These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1001743)

  • 1. Effect of steric exclusion by dextran on the conversion of fibrinogen into fibrin.
    Rampling MW; Lane DA; Kakkar VV
    Biochem Soc Trans; 1976; 4(4):688-90. PubMed ID: 1001743
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of dextran on clotting time: steric exclusion accelerates fibrin monomer polymerisation.
    Rampling MW; Lane DA; Kakkar VV
    Thromb Res; 1976 Oct; 9(4):379-86. PubMed ID: 10639
    [No Abstract]   [Full Text] [Related]  

  • 3. A two-step fibrinogen--fibrin transition in blood coagulation.
    Blombäck B; Hessel B; Hogg D; Therkildsen L
    Nature; 1978 Oct; 275(5680):501-5. PubMed ID: 692730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble fibrin-fibrinogen complexes as intermediates in fibrin gel formation.
    Wilf J; Minton AP
    Biochemistry; 1986 Jun; 25(11):3124-33. PubMed ID: 3730352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The binding of human plasminogen to fibrin and fibrinogen.
    Lucas MA; Fretto LJ; McKee PA
    J Biol Chem; 1983 Apr; 258(7):4249-56. PubMed ID: 6833255
    [No Abstract]   [Full Text] [Related]  

  • 6. Modification of fibrin network ultrastructure by Fab fragments specific for different domain of fibrinogen.
    Cierniewski CS; Janiak A; Wyroba E
    Acta Biochim Pol; 1986; 33(3):195-202. PubMed ID: 2433859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of fibrinogen-binding tetrapeptides with fibrin oligomers and fine fibrin clots.
    Schindlauer G; Bale MD; Ferry JD
    Biopolymers; 1986 Jul; 25(7):1315-36. PubMed ID: 3741995
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibitory effect of dextran 40 upon thrombin-induced fibrin deposition in rat lungs.
    Diffang C; Rammer L; Saldeen T
    Ups J Med Sci; 1976; 81(1):23-7. PubMed ID: 1273996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equilibria in the fibrinogen-fibrin conversion. IX. Effects of calcium ions on the reversible polymerization of fibrin monomer.
    Endres GF; Scheraga HA
    Arch Biochem Biophys; 1972 Nov; 153(1):266-78. PubMed ID: 4675447
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental tests of a geometrical abstraction of fibrin polymerization.
    Dietler G; Känzig W; Häberli A; Straub PW
    Biopolymers; 1986 May; 25(5):905-29. PubMed ID: 3719080
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of soluble polymerized fibrin formed in the presence of excess fibrinogen fragment D.
    Knoll D; Hantgan R; Williams J; McDonagh J; Hermans J
    Biochemistry; 1984 Jul; 23(16):3708-15. PubMed ID: 6236846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hyaluronic acid and other glycosaminoglycans on fibrin polymer formation.
    LeBoeuf RD; Gregg RR; Weigel PH; Fuller GM
    Biochemistry; 1987 Sep; 26(19):6052-7. PubMed ID: 3689758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of formation of fibrin oligomers. III. Ligation kinetics concurrent with and subsequent to oligomer assembly.
    Bale MD; Janmey PA; Ferry JD; Lorand L
    Biopolymers; 1984 Jan; 23(1):127-38. PubMed ID: 6141816
    [No Abstract]   [Full Text] [Related]  

  • 14. The fibrinogen-fibrin complex: stoichiometry and negative cooperativity.
    Usero JL; Burguillo FJ; Izquierdo C; Del Arco A; Herraez MA
    Thromb Res; 1985 Aug; 39(3):379-86. PubMed ID: 4049323
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fibrinogen-fibrin conversion].
    Shimizu A
    Seikagaku; 1990 Feb; 62(2):121-5. PubMed ID: 2329312
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of dextran on the conversion of fibrinogen to fibrin.
    LAURELL AB
    Scand J Clin Lab Invest; 1951; 3(4):262-6. PubMed ID: 14900980
    [No Abstract]   [Full Text] [Related]  

  • 17. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
    Achyuthan KE; Dobson JV; Greenberg CS
    Biochim Biophys Acta; 1986 Aug; 872(3):261-8. PubMed ID: 2873839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of the fibrinogen-binding tetrapeptide Gly-Pro-Arg-Pro with fine clots and oligomers of alpha-fibrin; comparisons with alpha beta-fibrin.
    Shimizu A; Schindlauer G; Ferry JD
    Biopolymers; 1988 May; 27(5):775-88. PubMed ID: 3382717
    [No Abstract]   [Full Text] [Related]  

  • 19. Location of plasminogen-binding sites in human fibrin(ogen).
    Váradi A; Patthy L
    Biochemistry; 1983 May; 22(10):2440-6. PubMed ID: 6222763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of fibrinogen to fibrin induced by preferential release of fibrinopeptide B.
    Dyr JE; Blombäck B; Hessel B; Kornalík F
    Biochim Biophys Acta; 1989 Jan; 990(1):18-24. PubMed ID: 2914147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.